First-trimester screening: Dealing with the fall-out

Prenatal Diagnosis

Volumn 31, Issue 1, 2011, Pages 46-49

  Fisher, Jane ^a  

^a Antenatal Results and Choices   (United Kingdom)

Author keywords

Cardiac blood flow; Down syndrome; First trimester screening; Maternal anxiety; Nasal bone; Nuchal translucency; Ultrasound markers

Indexed keywords

ANXIETY; ARTICLE; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REASSURANCE;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; DISEASES IN TWINS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 78650820625     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2687     Document Type: Article

References (17)

1. Antenatal Results and Choices. Evaluation of Combined Screening for Down's Syndrome in Four Units in South West London. ARC: London, in press.
2. Avgidou K, Papageorghious A, Bindra R, Spencer K, Nicolaides KH. 2005. Prospective first-trimester screening for trisomy 21 in 30, 564 patients. Am J Obstet Gynecol 192: 1761-1767.
3. Bahado-Singh RO, Wapner R, Thome E, et al. 2005. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 192: 1357-1361.
4. Bilardo CM, Muller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. 2007. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 30: 11-18.
5. Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. 2010. Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenat Diagn 30: 93-102.
6. Bryan E. 2005. Psychological aspects of prenatal diagnosis and its implications in multiple pregnancies. Prenat Diagn 25: 827-834.
7. Collado F, Bombard A, Li V, Aptekar L, Weiner Z. 2005. Ethnic variation of fetal nasal bone length between 11-14 weeks' gestation. Prenat Diagn 25: 690-692.
8. Clur SA, Ottenkamp J, Bilardo CM. 2009. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 29: 739-748.
9. Moonlight K. 2009. North East Regional Update in NHS Fetal Anomaly Screening Programme Progress Update. 12.
10. Nicolaides K. 2011. Screening for fetal aneuploidies. Prenat Diagn 31(1): 7-15.
11. NHS Fetal Anomaly Screening Programme, [Accessed on 21 December 2010].
12. Sonek JD, Cicero S, Neiger R, Nicolaides KH. 2006. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 195: 1219-1230.
13. Statham H, Solomou W, Chitty L. 2000. Prenatal diagnosis of fetal abnormality: psychological effects on women in low-risk pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 731-747.
14. UK National Screening Committee. 2008. Fetal Anomaly Screening Programme-Screening for Down's Syndrome: UK NSC Policy recommendations 2007-2010: Model of Best Practice.
15. Wan J, Schrimmer D, Tache V, et al. 2011. Current practices in determining amniocity and chorionicity in multiple gestations. Prenat Diagn 31(1): 125-130.
16. Watson MS, Hall S, Langford K, Marteau TM. 2002. Psychological impact of the detection of soft markers on routine ultrasound scanning: a pilot study investigating the modifying role of information. Prenat Diagn 22: 569-75.
17. Wright D, Syngelaki A, Staboulidou I, de Jesus Cruz J, Nicolaides KH. 2011. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn 31(1): 16-21.